Trial intelligence / Profile preview

Effects of remimazolam and propofol on circulatory parameters via mean circulatory filling pressure

jRCT1011240069Recruiting

Start
Jan 2025
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial in None comparing Remimazolam group with Propofol group (2 arms). Primary endpoint: Pmcf values over time. Started Jan 2025; status: recruiting.

02

Drugs

remimazolampropofol

Beyond the preview

Go deeper on jRCT1011240069.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1011240069.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call